Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

4.41
Delayed Data
As of Dec 05
 +0.17 / +4.01%
Today’s Change
2.94
Today|||52-Week Range
20.48
-72.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2017
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.009.0K14.0K19.0K
 
 
 
 
 
Operating ExpensesGross Income0.00-9.0K-14.0K-19.0K
 
 
 
 
General Expenses3.8M11.4M14.1M16.2M
 
 
 
 
 
Other Operating Expenses0.00-9.0K0.000.00
 
 
Research And Development3.1M8.7M11.0M12.5M
 
 
 
 
 
Total Operating Expenses3.8M11.4M14.1M16.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.8M-11.4M-14.1M-16.3M
 
 
 
 
 
Other Expenses15.0K-11.0K18.0K319.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.8M-11.4M-14.1M-15.9M
 
 
 
 
 
Net Income-3.8M-11.4M-14.1M-15.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.2M27.3M34.2M34.2M
 
 
 
 
 
Shares To Calculate EPS Diluted34.2M27.3M34.2M34.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11-$0.42-$0.42-$0.47
 
 
 
 
 
EPS Diluted-$0.11-$0.42-$0.41-$0.47